Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 764 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Washington D.C. DC, Fairfax VA, Baltimore MD, Newark DE,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06982521

Phase3, Recruiting
Active & Responsive

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

for
Advanced Esophageal Adenocarcinoma,
Location: Washington D.C. DC, Newark DE, Mechanicsburg PA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06203600

Phase2, Phase3, Recruiting
Active & Responsive

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

for
Autoimmune Disease, Crohn Disease, Dermatomyositis,
Location: Washington D.C. DC, Bethesda MD, Baltimore MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03816345

Phase1, Recruiting
Active & Responsive

Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

for
Cervical Cancer, Metastatic Cervical Cancer
Location: Washington D.C. DC, Hackensack NJ, Augusta GA
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT04865887

Phase2, Recruiting
Active & Responsive

A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle

for
Chondral Defect, Articular Cartilage Defect
Location: Washington D.C. DC, Charlottesville VA, Durham NC,
Sponsor: Vericel Corporation

Sex: All

Age: 17 - 65

Code: NCT06915233

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer

for
Metastatic Colorectal Adenocarcinoma,
Location: Washington D.C. DC, Baltimore MD, Atlanta GA, Aurora CO
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07147231

Phase1, Phase2, Recruiting
Active & Responsive

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

for
Extensive Stage Lung Small Cell Carcinoma,
Location: Washington D.C. DC, Baltimore MD, Richmond VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06287775

Phase1, Phase2, Recruiting
Active & Responsive

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

for
Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Location: Washington D.C. DC, Rockville MD, Philadelphia PA,
Sponsor: Electra Therapeutics Inc.

Sex: All

Age: 6+

Code: NCT05416307

Phase2, Phase3, Recruiting
Active & Responsive

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

for
Sickle Cell Disease
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT06439082

Phase3, Recruiting
Active & ResponsiveNew

NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors

for
Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma,
Location: Washington D.C. DC
Sponsor: Children's National Research Institute

Sex: All

Age: 3 - 25

Code: NCT07664176

Phase1, Recruiting
Active & ResponsiveNew

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Washington D.C. DC, Philadelphia PA, Boston MA,
Sponsor: Girish Dhall, MD

Sex: All

Age: 16+

Code: NCT06502171

Phase1, Recruiting
Active & Responsive

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

for
Neuroblastoma, Sarcoma
Location: Washington D.C. DC, The Bronx NY, Columbus OH,
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 40

Code: NCT05135975

Phase2, Recruiting
Active & Responsive

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

for
Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma,
Location: Washington D.C. DC, Baltimore MD, New York NY,
Sponsor: Carl Allen

Sex: All

Age: 0+

Code: NCT04079179

Phase2, Recruiting
Active & Responsive

Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia

for
Familial Hypercholesterolemia - Homozygous
Location: Washington D.C. DC, St Louis MO, Salt Lake City UT,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 11

Code: NCT06597006

Phase3, Recruiting
Active & Responsive

Advancing Transplantation Outcomes in Children

for
Kidney Transplant
Location: Washington D.C. DC, Baltimore MD, Wilmington DE,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 13 - 20

Code: NCT06055608

Phase2, Recruiting
Active & Responsive

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: Washington D.C. DC, Richmond VA, Wilmington DE,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 21

Code: NCT05183035

Phase3, Recruiting
Active & Responsive

Family Intervention for Black Teens With Type 1 Diabetes

for
Type 1 Diabetes, Family Relations
Location: Washington D.C. DC, Detroit MI, Memphis TN
Sponsor: Wayne State University

Sex: All

Age: 10 - 14

Code: NCT06275412

Recruiting
Active & Responsive

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

for
Diffuse Midline Glioma (DMG), Glioblastoma,
Location: Washington D.C. DC, Philadelphia PA, Ann Arbor MI,
Sponsor: Sabine Mueller, MD, PhD

Sex: All

Age: 2 - 21

Code: NCT04732065

Phase1, Recruiting
Active & Responsive

BBD Longitudinal Study of Osteogenesis Imperfecta

for
Osteogenesis Imperfecta
Location: Washington D.C. DC, Baltimore MD, Wilmington DE,
Sponsor: Baylor College of Medicine

Sex: All

Age: 0+

Code: NCT02432625

Recruiting
Active & Responsive

Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block

for
Heart Block Complete, Heart Block Second Degree
Location: Washington DC, New York NY, Toronto, Boston MA,
Sponsor: The Hospital for Sick Children

Sex: Female

Age: 16 - 50

Code: NCT04559425

Recruiting